Chu, Shuk Han,
Zhao, Xu,
Komber, Ahmad,
Cheyne, Joshua,
Wu, Simiao,
Cowey, Eileen,
Kutlubaev, Mansur,
Mead, Gillian (2023) reviews of randomized controlled
trials found insufficient evidence to guide practice, but most excluded
Surgery in Metastatic Seminoma: Negative
Trial Should Be Treated as Negative
Agaverdiev, Murad,
Shamsov, Bedil,
Mirzoev, Sorbon,
Vardikyan, Andranik,
Encarnacion, Manuel Ramirez,
Nurmukhametov, Renat,
Beilerli, Aferin,
Zhang, Bohan,
Gareev, Ilgiz,
Pavlov, Valentin (2023) into two stages.
Results: By August 2022, there were 149 registered clinical
trials. Most studies belong
, therapeutic approaches that target both diseases are needed. Clinical
trials are currently underway to explore
investigations and clinical
trials employed enhanced MSCs-dependent therapies in treatment of inflammatory
Bikbov, Mukharram M.,
Kazakbaeva, Gyulli M.,
Holz, Frank G.,
Panda-Jonas, Songhomitra,
Gilemzianova, Leisan I.,
Khakimov, Dinar A.,
Jonas, Jost B. (2023) or systemic adverse effects. During the study period, axial length remained unchanged.
Trial registration